SJS Investment Consulting’s MBX Biosciences MBX Stock Holding History

SJS Investment Consulting’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$111	Buy	+2	New	+$70	﹤0.01%	2591

Other funds holding MBX

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SJS Investment Consulting's MBX Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in MBX Biosciences (MBX) in Q2 2026: 2 shares worth $111. The stake represents ﹤0.01% of the portfolio and ranks #2591 among its holdings.

12 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

SJS Investment Consulting held 2 shares of MBX Biosciences worth $111 as of Q2 2026.
MBX Biosciences was a new SJS Investment Consulting position in Q2 2026.
MBX Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2591 holding.
12 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.